GENEGENETIC TECHNOLOGIES LTD

Nasdaq genetype.com


$ 2.34 $ 0.09 (4 %)    

Thursday, 09-May-2024 10:37:37 EDT
QQQ $ 440.52 $ 0.06 (0.01 %)
DIA $ 392.10 $ 1.62 (0.41 %)
SPY $ 518.72 $ 1.29 (0.25 %)
TLT $ 90.08 $ 0.04 (0.04 %)
GLD $ 215.77 $ 1.07 (0.5 %)
$ 2.25
$ 2.34
$ 2.25 x 100
$ 2.45 x 100
$ 2.34 - $ 2.34
$ 1.80 - $ 29.50
24,779
na
1.73M
$ 1.28
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 genetic-technologies-and-wellworks-for-you-sign-b2b-sales--marketing-deal-covering-750-employer-groups-and-2m-us-employees

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, &ldquo, Company&rdquo, , &ldquo, GTG&rdquo, )), a global ...

 genetic-technologies-announces-2m-registered-direct-offering-of-1m-ads-at-a-price-of-2ads

Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, ", Company", , ", GTG", , or ", Genetic Technologies&#...

 genetic-technologies-announced-tuesday-it-established-precision-oncology-division-announced-genetype-precision-oncology-brand-portfolio-of-new-diagnostic-tests

4 Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, &ldquo, Company&rdquo, , &ldquo, GTG&rdquo, )), a globa...

 genetic-technologies-digital-strategy-ignites-significant-traction-in-us-market

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION